STK6, also known by its more common name Aurora kinase A (AURKA), is a pivotal enzyme in the regulation of mitosis, the process by which a cell divides and shares its genetic material equally between two daughter cells. As a serine/threonine kinase, STK6's primary role is to ensure the correct separation of chromosomes by regulating the formation of the mitotic spindle, the structure that segregates chromosomes during cell division. The activity of STK6 is tightly controlled within the cell, with its expression levels fluctuating in sync with the cell cycle to meet the precise demands of cellular division. Its function is not only critical for normal cellular proliferation but also for maintaining the integrity of genomic material across generations of cells. Given its central role in cell division, STK6 is a subject of considerable interest in the study of cellular biology and the intricate mechanisms that govern cell proliferation and the maintenance of genomic stability.
Various chemical compounds can potentially induce the expression of STK6, providing valuable tools for researchers to study its role and regulation within the cell. These activators span a diverse range of substances, including small molecule inhibitors, growth factors, and other signaling molecules. For instance, retinoic acid can upregulate STK6 through its action on nuclear receptors that govern transcription, while epidermal growth factor (EGF) might stimulate its expression by triggering specific cell surface receptors that cascade into gene activation. Compounds like forskolin, which increases intracellular cAMP levels, can also enhance STK6 expression by activating downstream kinases that influence gene transcription. Moreover, agents that alter the epigenetic landscape of the cell, such as histone deacetylase inhibitors like Trichostatin A (TSA) or DNA methylation inhibitors like 5-Azacytidine, can lead to an upsurge in STK6 gene expression by modifying chromatin structure and accessibility. These chemical compounds serve as powerful probes to dissect the complex regulatory networks that control STK6 expression, shedding light on the sophisticated orchestration of cell cycle progression and the safeguarding of genomic fidelity.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Retinoic acid may boost STK6 expression by triggering retinoid receptor-mediated transcriptional activation, which typically promotes cell differentiation and can lead to an increase in proteins governing the cell cycle. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin may induce STK6 expression by elevating cAMP levels, which can activate protein kinase A (PKA) and subsequently enhance transcription of cell cycle-related genes, including those for mitotic kinases. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride could stimulate the upregulation of STK6 by inhibiting GSK-3, an enzyme that when suppressed, may lead to the stabilization and increased transcription of various cell cycle proteins. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A may increase STK6 levels by inhibiting histone deacetylase, thus relaxing chromatin structure at the STK6 gene locus and enabling transcriptional activation of this key mitotic regulator. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine could induce STK6 transcription by causing DNA demethylation, which can remove repressive marks and lead to the activation of gene expression, including cell cycle regulatory genes. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PMA may stimulate STK6 expression by activating protein kinase C (PKC), which in turn can enhance the transcription of genes involved in cell proliferation and mitotic spindle formation. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin could prompt STK6 upregulation by inhibiting mTOR signaling, which may cause a compensatory response that involves the enhanced expression of certain cell cycle drivers, including STK6. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 19 | |
Sodium butyrate might stimulate the expression of STK6 by its inhibitory effect on histone deacetylases, thereby increasing histone acetylation and promoting gene expression linked to cell cycle control. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $173.00 $418.00 | 43 | |
Doxorubicin may enhance STK6 expression as part of a cellular response to DNA damage, which necessitates the upregulation of cell cycle checkpoint proteins to maintain genomic integrity during mitosis. | ||||||
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $76.00 $255.00 | 18 | |
Hydroxyurea could lead to the increased transcription of STK6 by causing DNA replication stress, which in turn activates checkpoint pathways that upregulate genes essential for cell cycle progression and stability. | ||||||